Magnolia Medical Technologies patented initial specimen diversion for blood culture collection, both the technique, ISDT®, and the technology, Initial Specimen Diversion Device® (ISDD®). Our mission is to improve the diagnostic accuracy and timeliness for sepsis testing to achieve better outcomes for all patients, reduce hospital costs, and battle the global threat of antibiotic resistance.